Clarivate PLC
CLVT3.482USD
-0.008-0.24%
Market hours （ET）Quotes delayed by 15 min
2.30BMarket Cap
LossP/E TTM
More Details of Clarivate PLC Company
Clarivate Plc is a global provider of transformative intelligence. The Company offers enriched data, insights and analytics, workflow solutions and expert services in the areas of Academia & Government (A&G), Intellectual Property (IP) and Life Sciences & Healthcare (LS&H). Within the A&G segment, the Company offers solutions across various areas, which include scientific and academic research, information solutions and library software. Its ProQuest One solutions provide access to multidisciplinary curated content across a variety of formats, including data bases, dissertations, news, primary sources, books, and video. Within the IP segment, the Company provides IP data, software, and expertise to other companies to manage and protect critical IP assets. This segment's service offerings include IP management software, Patent services and Brand IP solutions, among others. Within the LS&H segment, the Company offers solutions across research and development, commercial and Medtech.
Clarivate PLC Info
Ticker SymbolCLVT
Company nameClarivate PLC
IPO dateOct 29, 2018
CEOTov (Matitiahu Shem)
Number of employees12000
Security typeOrdinary Share
Fiscal year-endOct 29
Address70 St. Mary Axe
CityLONDON
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited Kingdom
Postal codeEC3A 8BE
Phone442074334000
Websitehttps://clarivate.com/
Ticker SymbolCLVT
IPO dateOct 29, 2018
CEOTov (Matitiahu Shem)
Company Executives of Clarivate PLC
Name
Name/Position
Position
Shareholding
Change
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
419.24K
-42.50%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
341.06K
-17.18%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
299.94K
-38.66%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
116.52K
+42.06%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
101.81K
+41.73%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+57.91%
Mr. Kenneth L. Cornick
Mr. Kenneth L. Cornick
Director
Director
32.71K
+9.20%
Mr. Jane Okun Bomba, CPA
Mr. Jane Okun Bomba, CPA
Independent Director
Independent Director
--
--
Ms. Suzanne Heywood
Ms. Suzanne Heywood
Independent Director
Independent Director
--
--
Mr. Usama N. Cortas
Mr. Usama N. Cortas
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Bar Veinstein
Mr. Bar Veinstein
President - Academia and Government
President - Academia and Government
419.24K
-42.50%
Mr. Henry Levy
Mr. Henry Levy
President - Life Sciences and Health care
President - Life Sciences and Health care
341.06K
-17.18%
Mr. Jonathan Mark Collins
Mr. Jonathan Mark Collins
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
299.94K
-38.66%
Dr. Saurabh Saha, M.D., Ph.D.
Dr. Saurabh Saha, M.D., Ph.D.
Independent Director
Independent Director
116.52K
+42.06%
Dr. Wendell E. Pritchett
Dr. Wendell E. Pritchett
Independent Director
Independent Director
101.81K
+41.73%
Ms. Valeria Alberola
Ms. Valeria Alberola
Independent Director
Independent Director
91.16K
+57.91%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Subscription revenues
405.70M
65.29%
Re-occurring revenues
108.90M
17.52%
Transactional revenues
106.80M
17.19%
By RegionUSD
Name
Revenue
Proportion
Americas
331.90M
53.41%
Europe/ Middle East /Africa
164.90M
26.54%
Asia Pacific
124.60M
20.05%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Subscription revenues
405.70M
65.29%
Re-occurring revenues
108.90M
17.52%
Transactional revenues
106.80M
17.19%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Leonard Green & Partners, L.P.
17.64%
Giovanni Agnelli B V
10.17%
Clarkston Capital Partners, LLC
10.09%
Impactive Capital LP
6.50%
Onex Corporation
6.34%
Other
49.26%
Shareholders
Shareholders
Proportion
Leonard Green & Partners, L.P.
17.64%
Giovanni Agnelli B V
10.17%
Clarkston Capital Partners, LLC
10.09%
Impactive Capital LP
6.50%
Onex Corporation
6.34%
Other
49.26%
Shareholder Types
Shareholders
Proportion
Private Equity
31.46%
Investment Advisor
28.67%
Hedge Fund
15.23%
Investment Advisor/Hedge Fund
10.34%
Holding Company
10.17%
Corporation
5.76%
Pension Fund
1.77%
Research Firm
1.05%
Individual Investor
1.03%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
535
592.98M
105.89%
+6.90K
2025Q3
602
592.98M
107.55%
-12.23M
2025Q2
641
615.33M
113.09%
-20.61M
2025Q1
673
634.58M
117.94%
-171.09M
2024Q4
687
649.99M
118.14%
-11.56M
2024Q3
702
655.24M
113.94%
+3.30M
2024Q2
715
650.43M
105.77%
+33.49M
2024Q1
726
617.29M
113.75%
-142.82M
2023Q4
754
617.55M
121.55%
-46.09M
2023Q3
759
661.45M
111.82%
+27.54M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Leonard Green & Partners, L.P.
116.67M
17.36%
--
--
Jun 30, 2025
Giovanni Agnelli B V
67.29M
10.01%
--
--
Jun 30, 2025
Clarkston Capital Partners, LLC
70.03M
10.42%
-4.50M
-6.03%
Jun 30, 2025
Impactive Capital LP
43.03M
6.4%
--
--
Jun 30, 2025
Onex Corporation
41.92M
6.24%
-938.25K
-2.19%
Mar 10, 2025
Selige Co-Investor Pooling SCSp
38.09M
5.67%
--
--
Mar 10, 2025
Partners Group AG
25.58M
3.81%
--
--
Jun 30, 2025
Fidelity Investments Canada ULC
16.88M
2.51%
+680.60K
+4.20%
Jun 30, 2025
Cambridge Information Group, Inc.
23.90M
3.56%
+290.94K
+1.23%
Mar 10, 2025
Dimensional Fund Advisors, L.P.
21.07M
3.13%
+4.48M
+26.98%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust Technology Alphadex
1.17%
Avantis US Small Cap Value ETF
0.16%
WisdomTree US MidCap Fund
0.14%
DFA Dimensional US Small Cap Value ETF
0.13%
JPMorgan US Value Factor ETF
0.13%
Nuveen ESG Small-Cap ETF
0.09%
John Hancock Multifactor Small Cap ETF
0.09%
Avantis US Small Cap Equity ETF
0.08%
Invesco RAFI US 1500 Small-Mid ETF
0.08%
BNY Mellon US Small Cap Core Equity ETF
0.07%
View more
First Trust Technology Alphadex
Proportion1.17%
Avantis US Small Cap Value ETF
Proportion0.16%
WisdomTree US MidCap Fund
Proportion0.14%
DFA Dimensional US Small Cap Value ETF
Proportion0.13%
JPMorgan US Value Factor ETF
Proportion0.13%
Nuveen ESG Small-Cap ETF
Proportion0.09%
John Hancock Multifactor Small Cap ETF
Proportion0.09%
Avantis US Small Cap Equity ETF
Proportion0.08%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0.08%
BNY Mellon US Small Cap Core Equity ETF
Proportion0.07%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Clarivate PLC?
The top five shareholders of Clarivate PLC are:
Leonard Green & Partners, L.P. holds 116.67M shares, accounting for 17.36% of the total shares.
Giovanni Agnelli B V holds 67.29M shares, accounting for 10.01% of the total shares.
Clarkston Capital Partners, LLC holds 70.03M shares, accounting for 10.42% of the total shares.
Impactive Capital LP holds 43.03M shares, accounting for 6.40% of the total shares.
Onex Corporation holds 41.92M shares, accounting for 6.24% of the total shares.
Leonard Green & Partners, L.P. holds 116.67M shares, accounting for 17.36% of the total shares.
Giovanni Agnelli B V holds 67.29M shares, accounting for 10.01% of the total shares.
Clarkston Capital Partners, LLC holds 70.03M shares, accounting for 10.42% of the total shares.
Impactive Capital LP holds 43.03M shares, accounting for 6.40% of the total shares.
Onex Corporation holds 41.92M shares, accounting for 6.24% of the total shares.
What are the top three shareholder types of Clarivate PLC?
The top three shareholder types of Clarivate PLC are:
Leonard Green & Partners, L.P.
Giovanni Agnelli B V
Clarkston Capital Partners, LLC
Leonard Green & Partners, L.P.
Giovanni Agnelli B V
Clarkston Capital Partners, LLC
How many institutions hold shares of Clarivate PLC (CLVT)?
As of 2025Q4, 535 institutions hold shares of Clarivate PLC, with a combined market value of approximately 592.98M, accounting for 105.89% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -1.65%.
What is the biggest source of revenue for Clarivate PLC?
In FY2025Q2, the Subscription revenues business generated the highest revenue for Clarivate PLC, amounting to 405.70M and accounting for 65.29% of total revenue.
